CLEVELAND--(EON: Enhanced Online News)--Excelerate today announced that Temple University Health System (TUHS), one of Philadelphia’s leading academic medical centers, has become the newest member of its industry-leading, provider-led sourcing model. TUHS will utilize Excelerate’s value-based clinical portfolio of physician preference items, surgical and specialty products and other clinical items to achieve immediate and sustainable savings.
“Excelerate considerably increases our group-purchasing leverage to acquire the best clinical and non-clinical supplies, equipment and services at even lower prices to take the best care of our patients”
Excelerate is a joint venture between Cleveland Clinic, Vizient, Inc., and OhioHealth and is designed to provide enhanced value to members by offering a unique, physician-driven and evidence-based approach to sourcing.
Temple University Health System chose to join Excelerate due to its proven evidence-based, physician and clinician engaged product selection process and utilization guidelines designed to decrease clinical variation in support of cost-effective care delivery.
“Excelerate considerably increases our group-purchasing leverage to acquire the best clinical and non-clinical supplies, equipment and services at even lower prices to take the best care of our patients,” said Verdi J. DiSesa, MD, MBA, President and CEO of Temple University Hospital, Senior Vice Dean for Clinical Affairs at the Lewis Katz School of Medicine at Temple University and Chief Operating Officer for Temple University Health System. “Through this collaboration we expect to achieve the dual-goal of lowering costs while still enhancing the value of the care we provide.”
Excelerate’s provider-led, physician and clinician engaged sourcing model delivers significant savings to its members through:
- Execution of best-in-class contracts driving member value
- Peer-to-peer physician engagement that fosters clinical alignment and enables local change
- Utilization guidelines mapping to decreased clinical variation
“Our operating philosophies are closely aligned, making this an ideal collaboration that will deliver significant benefit,” said Sean Lyden, MD, Chief Medical Officer for Excelerate and Department Chair of Vascular Surgery for the Cleveland Clinic. “In a rapidly changing healthcare environment in which many providers are facing increasing cost pressure, our alignment will be able to accelerate speed to value for Temple in a fashion that preserves Temple’s legacy for patient-focused quality and affordability.”
Excelerate is designed to deliver significant and substantial savings to health care organizations through a provider-led, physician-engaged sourcing company. Excelerate achieves this through executing data-driven, market-leading contracts, clinical utilization guidelines designed to decrease clinical variation, and providing peer-to-peer physician engagement that fosters clinical alignment enabling local change. Excelerate started in 2013 as a joint venture between Cleveland Clinic and Vizient, Inc. In 2016, OhioHealth was added as an equity owner and member. Click here to learn more about Excelerate.
About Temple Health
Temple University Health System (TUHS) is a $1.6 billion academic health system dedicated to providing access to quality patient care and supporting excellence in medical education and research. The Health System consists of Temple University Hospital (TUH), ranked among the “Best Hospitals” in the region by U.S. News & World Report; TUH-Episcopal Campus; TUH-Northeastern Campus; Fox Chase Cancer Center, an NCI-designated comprehensive cancer center; Jeanes Hospital, a community-based hospital offering medical, surgical and emergency services; Temple Transport Team, a ground and air-ambulance company; and Temple Physicians, Inc., a network of community-based specialty and primary-care physician practices. TUHS is affiliated with the Lewis Katz School of Medicine at Temple University.
The Lewis Katz School of Medicine (LKSOM), established in 1901, is one of the nation’s leading medical schools. Each year, the School of Medicine educates approximately 840 medical students and 140 graduate students. Based on its level of funding from the National Institutes of Health, the Katz School of Medicine is the second-highest ranked medical school in Philadelphia and the third-highest in the Commonwealth of Pennsylvania. According to U.S. News & World Report, LKSOM is among the top 10 most applied-to medical schools in the nation.
Temple Health refers to the health, education and research activities carried out by the affiliates of Temple University Health System (TUHS) and by the Katz School of Medicine. TUHS neither provides nor controls the provision of health care. All health care is provided by its member organizations or independent health care providers affiliated with TUHS member organizations. Each TUHS member organization is owned and operated pursuant to its governing documents.